Roberto Ria

11.3k total citations
160 papers, 6.5k citations indexed

About

Roberto Ria is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Roberto Ria has authored 160 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 69 papers in Molecular Biology and 53 papers in Oncology. Recurrent topics in Roberto Ria's work include Multiple Myeloma Research and Treatments (77 papers), Angiogenesis and VEGF in Cancer (24 papers) and Platelet Disorders and Treatments (19 papers). Roberto Ria is often cited by papers focused on Multiple Myeloma Research and Treatments (77 papers), Angiogenesis and VEGF in Cancer (24 papers) and Platelet Disorders and Treatments (19 papers). Roberto Ria collaborates with scholars based in Italy, Germany and United Kingdom. Roberto Ria's co-authors include Angelo Vacca, Doménico Ribatti, Franco Dammacco, Beatrice Nico, Monica Iurlaro, Marco Presta, Luisa Roncali, Monica Minischetti, Federico Bussolino and Adriana Albini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Roberto Ria

155 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Ria Italy	47	3.4k	3.1k	2.3k	1.1k	937	160	6.5k
Karin Vanderkerken Belgium	51	4.5k 1.3×	3.6k 1.1×	3.2k 1.3×	1.2k 1.1×	1.4k 1.5×	227	7.9k
Dirk Hose Germany	48	4.4k 1.3×	3.5k 1.1×	2.1k 0.9×	1.2k 1.0×	665 0.7×	210	6.8k
Aldo M. Roccaro United States	50	4.5k 1.3×	2.9k 0.9×	2.0k 0.8×	1.3k 1.2×	1.7k 1.9×	203	7.6k
Itaru Matsumura Japan	39	2.5k 0.7×	2.0k 0.6×	1.4k 0.6×	1.1k 1.0×	503 0.5×	216	5.5k
Nicola Giuliani Italy	48	3.1k 0.9×	3.4k 1.1×	3.3k 1.4×	804 0.7×	642 0.7×	199	6.8k
Daniela S. Krause United States	30	2.8k 0.8×	1.8k 0.6×	1.6k 0.7×	1.3k 1.2×	536 0.6×	74	6.0k
Danilo Perrotti United States	50	5.9k 1.7×	3.2k 1.0×	1.2k 0.5×	1.3k 1.1×	2.1k 2.2×	123	9.0k
Rishu Takimoto Japan	40	2.6k 0.8×	1.2k 0.4×	1.6k 0.7×	593 0.5×	564 0.6×	155	5.8k
Beate Heissig Japan	33	5.1k 1.5×	1.9k 0.6×	2.6k 1.1×	1.5k 1.3×	2.4k 2.6×	74	8.7k
Justus Duyster Germany	52	3.9k 1.2×	3.5k 1.1×	2.4k 1.0×	1.5k 1.3×	1.2k 1.2×	261	9.0k

Countries citing papers authored by Roberto Ria

Since Specialization

Citations

This map shows the geographic impact of Roberto Ria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ria more than expected).

Fields of papers citing papers by Roberto Ria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Ria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ria. The network helps show where Roberto Ria may publish in the future.

Co-authorship network of co-authors of Roberto Ria

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Ria. A scholar is included among the top collaborators of Roberto Ria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Ria. Roberto Ria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boscia, Giacomo, Vanessa Desantis, Antonio Giovanni Solimando, et al.. (2025). Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature. Journal of Clinical Medicine. 14(7). 2487–2487. 1 indexed citations

D’Agostino, Mattia, Marina Martello, Lorenzo De Paoli, et al.. (2025). Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts. Annals of Hematology. 104(3). 1443–1458. 1 indexed citations

Saltarella, Ilaria, Concetta Altamura, Antonio Giovanni Solimando, et al.. (2024). Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management. Cancers. 16(18). 3190–3190. 3 indexed citations

Jolles, Stephen, Sergio Giralt, Tessa Kerre, et al.. (2023). Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review. Frontiers in Oncology. 13. 1098326–1098326. 10 indexed citations

Cicco, Sebastiano, Claudia Morelli, Davide Fiore Bavaro, et al.. (2023). Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study. Medicina. 59(2). 203–203. 1 indexed citations

Palano, Maria Teresa, Natalia Platonova, Germano Gaudenzi, et al.. (2020). Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells. Cancers. 12(9). 2600–2600. 7 indexed citations

Saltarella, Ilaria, Maria Antonia Frassanito, Aurelia Lamanuzzi, et al.. (2018). Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?. Neoplasia. 21(1). 93–105. 29 indexed citations

Moschetta, Michele, Maria Antonia Frassanito, Simona Berardi, et al.. (2014). A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target. Clinical Cancer Research. 20(22). 5796–5807. 53 indexed citations

Moschetta, Michele, Antonio Basile, Maria Antonia Frassanito, et al.. (2013). Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma. Clinical Cancer Research. 19(16). 4371–4382. 54 indexed citations

10.

Ria, Roberto, Ivana Catacchio, Simona Berardi, et al.. (2013). HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target. Clinical Cancer Research. 20(4). 847–858. 50 indexed citations

11.

Moschetta, Michele, Paolo Ditonno, Roberto Ria, et al.. (2012). Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients. The Journal of Pathology. 229(1). 87–98. 31 indexed citations

12.

Ria, Roberto, Katia Todoerti, Simona Berardi, et al.. (2009). Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma. Clinical Cancer Research. 15(17). 5369–5378. 75 indexed citations

13.

Moschetta, Michele, Giulia Di Pietro, Roberto Ria, et al.. (2009). Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. European Journal of Cancer. 46(2). 420–429. 51 indexed citations

14.

Matricardi, Pietro, Claudia Cencetti, Roberto Ria, Franco Alhaique, & Tommasina Coviello. (2009). Preparation and Characterization of Novel Gellan Gum Hydrogels Suitable for Modified Drug Release. Molecules. 14(9). 3376–3391. 93 indexed citations

15.

Palumbo, Antonio, Sara Bringhen, Anna Marina Liberati, et al.. (2008). Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood. 112(8). 3107–3114. 250 indexed citations

16.

Ria, Roberto, Cláudia Piccoli, Teresa Cirulli, et al.. (2008). Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma. Clinical Cancer Research. 14(6). 1678–1685. 37 indexed citations

17.

Vacca, Angelo, Doménico Ribatti, Monica Iurlaro, et al.. (2002). Docetaxel Versus Paclitaxel for Antiangiogenesis. Journal of Hematotherapy & Stem Cell Research. 11(1). 103–118. 111 indexed citations

18.

Ribatti, Domenico, Angelo Vacca, Andrea Marzullo, et al.. (2000). Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of Cancer. 85(2). 171–175. 129 indexed citations

19.

Ribatti, Doménico, Angelo Vacca, Andrea Marzullo, et al.. (2000). Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of Cancer. 85(2). 171–175. 67 indexed citations

20.

Minischetti, Monica, Angelo Vacca, Doménico Ribatti, et al.. (2000). TNP‐470 and recombinant human interferon‐α2a inhibit angiogenesis synergistically. British Journal of Haematology. 109(4). 829–837. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact